NAMS envisions a sustainable, high quality, affordable and patient focused care healthcare system in India, possible when steered by a special Cell comprising MoHFW, NAMS, NITI...
Investment for companies developing digital pathology solutions has spiked to more than $1.7B since 2014, with 42.4% of this total funding ($741.8M) raised during 2021. Only...
We expect pharmaceuticals companies under our coverage to report healthy Ebitda growth of 19% YoY (down 8% QoQ), mainly aided by steady domestic growth and new...
Copyright © 2023 Medical Buyer